Cliff Smith Joins PetVivo Holdings, Inc. as the Regional Sales Manager
March 08 2022 - 07:00AM
PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company")
an emerging biomedical device company focused on the
commercialization of innovative medical devices and therapeutics
for companion animals is pleased to announce that Cliff Smith has
accepted a position with the Company as its new Regional Sales
Manager for the Southeast Region of the United States.
"Cliff adds a key component to accomplishing our
corporate goals related to sales and distribution of our
revolutionary product Spryng™ with OsteoCushion™ technology. The
focus on sales has become a key objective to the success of our
Company and we believe the vast insight and expertise that Cliff
brings to PetVivo puts us in an excellent position to meet this
objective,” said John Lai, Chief Executive Officer of PetVivo
Holdings, Inc. “Cliff is excellent in promoting and selling
veterinary products. These skills will propel the sale of our
veterinary medical device, Spryng, for use in companion
animals."
Mr. Smith has more than 25 years of experience
related to distribution and manufacturing of veterinary products in
the Southeast region of the United States. He began his career
working for the Hunt family in their cattle and cutting horse
operations, which transitioned to training, breeding and racing
thoroughbred horses. Mr. Smith next advanced his career to
veterinary product distribution by taking a position with Milburn
Distributions where he remained for approximately twenty years and
assisted in growing Milburn to one of the largest equine veterinary
distribution companies in the world. In 2017, he began working as a
consultant for numerous veterinary products companies
commercializing products and equipment with a focus on equine and
mixed animal. Mr. Smith graduated from Texas A&M, class of
1981, where he completed a Bachelor of Science degree in
Agricultural Economics.
“I am incredibly excited to join the PetVivo
sales and marketing team. PetVivo’s technology has tremendous
potential to enhance the lives of companion animals and their
owners,” said Mr. Smith. “I am looking forward to joining a company
that possesses a ground-breaking technology and has the ability to
grow the market with a product that has been shown to improve the
medical outcomes of animals.”
For more information about PetVivo Holdings,
Inc. and its innovative product, Spryng, please contact
info1@petvivo.com or visit https://petvivo.com/ and
https://sprynghealth.com/
About PetVivo Holdings,
Inc.
PetVivo Holdings Inc. (NASDAQ: PETV) is an
emerging biomedical device company currently focused on the
manufacturing, commercialization and licensing of innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies for the treatment
of companion animals in a capital and time efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for
the treatment of animals and people. A portfolio of nineteen
patents protects the Company's biomaterials, products, production
processes and methods of use. The Company’s lead product SPRYNG, a
veterinarian-administered, intraarticular injection for the
treatment of lameness and other joint related afflictions,
including osteoarthritis, in dogs and horses, is currently
available for commercial sale to veterinarians.
CONTACT:
John Lai, CEOPetVivo Holdings, Inc.Email:
info1@petvivo.com(952) 405-6216
Forward-Looking commercial
Statements:
The foregoing material may contain
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, each as amended. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, including without limitation the Company’s proposed
development and commercial timelines, and can be identified by the
use of words such as “may,” “will,” “expect,” “project,”
“estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,”
“continue” or the negative versions of those words or other
comparable words. Forward-looking statements are not guarantees of
future actions or performance. These forward-looking statements,
including the potential listing of the Company’s common stock on
Nasdaq, are based on information currently available the Company
and its current plans or expectations and are subject to a number
of uncertainties and risks that could significantly affect current
plans. Risks concerning the Company’s business are described in
detail in the Company’s Annual Report on Form 10-K for the year
ended March 31, 2021 and other periodic and current reports filed
with the Securities and Exchange Commission. The Company is under
no obligation to, and expressly disclaims any such obligation to,
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
PetVivo (NASDAQ:PETVW)
Historical Stock Chart
From Feb 2024 to Mar 2024
PetVivo (NASDAQ:PETVW)
Historical Stock Chart
From Mar 2023 to Mar 2024